- Home
- GITS vs BGLC Comparison
GITS vs BGLC Comparison
Compare GITS & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GITS
- BGLC
- Stock Information
- Founded
- GITS 2018
- BGLC 2017
- Country
- GITS South Korea
- BGLC Malaysia
- Employees
- GITS N/A
- BGLC N/A
- Industry
- GITS
- BGLC Medical Specialities
- Sector
- GITS
- BGLC Health Care
- Exchange
- GITS Nasdaq
- BGLC Nasdaq
- Market Cap
- GITS 5.1M
- BGLC 5.0M
- IPO Year
- GITS N/A
- BGLC N/A
- Fundamental
- Price
- GITS $1.38
- BGLC $2.71
- Analyst Decision
- GITS
- BGLC
- Analyst Count
- GITS 0
- BGLC 0
- Target Price
- GITS N/A
- BGLC N/A
- AVG Volume (30 Days)
- GITS 2.9M
- BGLC 69.9K
- Earning Date
- GITS 07-15-2025
- BGLC 08-13-2025
- Dividend Yield
- GITS N/A
- BGLC N/A
- EPS Growth
- GITS N/A
- BGLC N/A
- EPS
- GITS N/A
- BGLC N/A
- Revenue
- GITS N/A
- BGLC $9,265,870.00
- Revenue This Year
- GITS N/A
- BGLC N/A
- Revenue Next Year
- GITS N/A
- BGLC N/A
- P/E Ratio
- GITS N/A
- BGLC N/A
- Revenue Growth
- GITS N/A
- BGLC N/A
- 52 Week Low
- GITS $0.87
- BGLC $2.01
- 52 Week High
- GITS $9.78
- BGLC $8.40
- Technical
- Relative Strength Index (RSI)
- GITS N/A
- BGLC 43.64
- Support Level
- GITS N/A
- BGLC $2.60
- Resistance Level
- GITS N/A
- BGLC $3.06
- Average True Range (ATR)
- GITS 0.00
- BGLC 0.21
- MACD
- GITS 0.00
- BGLC -0.06
- Stochastic Oscillator
- GITS 0.00
- BGLC 16.27
About GITS Global Interactive Technologies Inc. Common Stock
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.